Korean Circ J.  2018 May;48(5):438-441. 10.4070/kcj.2017.0364.

Transseptal Transcatheter Mitral Valve-in-valve Replacement for a Failed Bioprosthetic Mitral Valve

• Kang DY
• Ahn JM
• Lee CH
• Kang SH
• Heo R
• Park DW
• Song JM
• Park SJ

• KMID: 2414915
• DOI: http://doi.org/10.4070/kcj.2017.0364

Abstract

No abstract available.

MeSH Terms

Mitral Valve*

Figure

• 

  Figure 1 Hancock II bioprosthetic mitral valve and its fluoroscopic image.

• 

  Figure 2 (A) Balloon atrial septostomy with 10×40mm balloon. (B) Positioning of Edwards SAPIEN 3 valve within surgical bioprosthesis over a Safari wire. (C) Deployment of SAPIEN 3 valve under rapid ventricular pacing. (D) The left ventriculogram without significant mitral regurgitation after valve deployment.

• 

  Figure 3 The final fluoroscopic image of mitral valve after the procedure.

Reference

1. Bourguignon T, Bouquiaux-Stablo AL, Loardi C, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations. J Thorac Cardiovasc Surg. 2014; 148:2004–2011.e1.

2. Jones JM, O’Kane H, Gladstone DJ, et al. Repeat heart valve surgery: risk factors for operative mortality. J Thorac Cardiovasc Surg. 2001; 122:913–918.

3. Paradis JM, Del Trigo M, Puri R, Rodés-Cabau J. Transcatheter valve-in-valve and valve-in-ring for treating aortic and mitral surgical prosthetic dysfunction. J Am Coll Cardiol. 2015; 66:2019–2037.

4. Yoon SH, Whisenant BK, Bleiziffer S, et al. Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings. J Am Coll Cardiol. 2017; 70:1121–1131.